Keynote Presentations

A Look Back and a Look Ahead: Perspectives from Cell Line Development at a Large Biotechnology and Now Pharma Company

John Joly, Ph.D.
Director of Early Stage Cell Culture, Process Development
Genentech, Inc.

Putting the CHO Genome to Work: Illustrations to Increase Transgene Integration and Expression and to Improve Protein Processing

Nicolas Mermod, Ph.D.
Professor, Director, Institute of Biotechnology
University of Lausanne, Switzerland

Featured Presentation

An Update on the International Community's Efforts at CHOgenome.org

Kelvin H. Lee, Ph.D.
Gore Professor of Chemical Engineering, Director of the Delaware Biotechnology Institute
University of Delaware

New to the Field?

Attend the Two-Day Short Course:
Cell Line Development for Protein Therapeutics Manufacturing in Mammalian Systems
Thursday-Friday, June 7-8, 2012
(Separate Registration Required - Add Wednesday for a 3-Day Package)

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until May 11, 2012.
To book your room, call 888-627-8561 and mention that you are an IBC attendee at this event.

Recent Achievements Driven by the Application of Novel Approaches and Tools Have Caused Significant Savings in Time and Money During the Selection and Development of Cell Lines

IBC's Cell Line Development & Engineering conference will deliver the latest applications of automated tools, 'omics technologies, analytical methods and engineering strategies to help increase understanding and improve the stability, quality and manufacturability of your cell lines. You will hear the latest case studies and unpublished data from industry and academia and have the opportunity to collectively collaborate with your peers during strategic discussion groups and interactive roundtables to overcome your most pressing challenges and help your company:

• Streamline the transition from discovery to development
• Put the CHO genome to work to improve protein expression
• Improve predictability in early development
• Apply 'omics technologies and next generation sequencing to optimize development and understanding
• Test safety of engineered cell lines using massively parallel sequencing
• Develop cell lines and cell culture processes for biosimilars
• Implement a targeted integration approach that greatly reduces development time and cost and increases throughput
• Decrease levels of N-linked glycosylation to greatly increase biological activity
• Adopt PAT to improve clone selection, process understanding and development

Plus! Interactive CHO Genome "Show and Tell" Workshop

• Learn the next steps that should be taken
• Hear case studies that walk you through the use of the web tools to see how it works
• Get expert guidance and your questions answered on using the web tools to fully utilize the genome-scale data

"This is an outstanding venue for bringing together experts in the field, vendors, scientists and other interested parties, and the collaborative and open environment has always been rewarding. This meeting is on my calendar every year!" - Gene Lee, EMD Serono